The safety and efficacy of PD-1 inhibitors in patients with advanced cancers and HIV/AIDS in China
Conclusions-This study demonstrates that camrelizumab treatment in patients with advanced cancers and HIV/AIDS was feasible and the clinical outcomes were acceptable.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | China Health | Clinical Trials | HIV AIDS | Hodgkin's Disease | Immunotherapy | Lymphoma | Non-Hodgkin's Lymphoma | Study | Women